Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i> -mutated melanoma

Michael G. White, Robert Szczepaniak Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews, Ningping Feng, Sarah Johnson, Caleb A. Class, Christopher Bristow, Khalida Wani, Courtney Hudgens, Luigi Nezi, Teresa Manzo, Mariana Pettaccia De Macedo, Jianhua Hu, Richard Davis, Hong Jiang, Peter Prieto, Elizabeth Burton, Patrick Hwu, Hussein Tawbi, Jeffrey Gershenwald, Alexander J. Lazar, Michael T. Tetzlaff, Willem Overwijk, Scott E Woodman, Zachary A. Cooper, Joseph R. Marszalek, Michael A. Davies, Timothy P. Heffernan, Jennifer A. Wargo

Open source

DOI: 10.1080/2162402x.2021.1992880
Published: 2021-01
Container: OncoImmunology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/2162402x.2021.1992880,
  title = {Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in
                    <i>Braf</i>
                    -mutated melanoma},
  author = {Michael G. White and Robert Szczepaniak Sloane and Russell G. Witt and Alexandre Reuben and Pierre Olivier Gaudreau and Miles C. Andrews and Ningping Feng and Sarah Johnson and Caleb A. Class and Christopher Bristow and Khalida Wani and Courtney Hudgens and Luigi Nezi and Teresa Manzo and Mariana Pettaccia De Macedo and Jianhua Hu and Richard Davis and Hong Jiang and Peter Prieto and Elizabeth Burton and Patrick Hwu and Hussein Tawbi and Jeffrey Gershenwald and Alexander J. Lazar and Michael T. Tetzlaff and Willem Overwijk and Scott E Woodman and Zachary A. Cooper and Joseph R. Marszalek and Michael A. Davies and Timothy P. Heffernan and Jennifer A. Wargo},
  year = {2021},
  journal = {OncoImmunology},
  doi = {10.1080/2162402x.2021.1992880},
  url = {https://doi.org/10.1080/2162402x.2021.1992880}
}

RIS

TY  - JOUR
TI  - Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in
                    <i>Braf</i>
                    -mutated melanoma
AU  - Michael G. White
AU  - Robert Szczepaniak Sloane
AU  - Russell G. Witt
AU  - Alexandre Reuben
AU  - Pierre Olivier Gaudreau
AU  - Miles C. Andrews
AU  - Ningping Feng
AU  - Sarah Johnson
AU  - Caleb A. Class
AU  - Christopher Bristow
AU  - Khalida Wani
AU  - Courtney Hudgens
AU  - Luigi Nezi
AU  - Teresa Manzo
AU  - Mariana Pettaccia De Macedo
AU  - Jianhua Hu
AU  - Richard Davis
AU  - Hong Jiang
AU  - Peter Prieto
AU  - Elizabeth Burton
AU  - Patrick Hwu
AU  - Hussein Tawbi
AU  - Jeffrey Gershenwald
AU  - Alexander J. Lazar
AU  - Michael T. Tetzlaff
AU  - Willem Overwijk
AU  - Scott E Woodman
AU  - Zachary A. Cooper
AU  - Joseph R. Marszalek
AU  - Michael A. Davies
AU  - Timothy P. Heffernan
AU  - Jennifer A. Wargo
PY  - 2021
JO  - OncoImmunology
DO  - 10.1080/2162402x.2021.1992880
UR  - https://doi.org/10.1080/2162402x.2021.1992880
ER  -

APA

White, M. G., Sloane, R. S., Witt, R. G., Reuben, A., Gaudreau, P. O., Andrews, M. C., Feng, N., Johnson, S., Class, C. A., Bristow, C., Wani, K., Hudgens, C., Nezi, L., Manzo, T., Macedo, M. P. D., Hu, J., Davis, R., Jiang, H., Prieto, P., Burton, E., Hwu, P., Tawbi, H., Gershenwald, J., Lazar, A. J., Tetzlaff, M. T., Overwijk, W., Woodman, S. E., Cooper, Z. A., Marszalek, J. R., Davies, M. A., Heffernan, T. P., & Wargo, J. A. (2021). Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i> -mutated melanoma. OncoImmunology. https://doi.org/10.1080/2162402x.2021.1992880

Source records

crossref · retrieved 2026-09-27T04:07:30.837Z